Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Protagonist Therapeutics Stock News

PTGXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$45.82

0.200.44%

At close: -

$45.82

0.000.00%

After Hours: 4:00 PM EDT

Protagonist Therapeutics (PTGX) Forecast

News

Earnings Protagonist Therapeutics (PTGX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Protagonist Therapeutics Stock News | NASDAQ:PTGX | Benzinga

Get the latest news on Protagonist Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Protagonist Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, April 10, 2025

HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Apr 10, 2025, 12:52PM
Johnson & Johnson, Protagonist Tout Positive Results For Psoriasis Oral Pill Study
Vandana Singh - Apr 10, 2025, 10:20AM
Johnson & Johnson Presents Icotrokinra Result...
Benzinga Newsdesk - Apr 10, 2025, 8:08AM

Friday, March 28, 2025

Wedbush Reiterates Outperform on Protagonist ...
Benzinga Newsdesk - Mar 28, 2025, 9:44AM

Sunday, March 16, 2025

D-Wave Quantum And IonQ Are Among Top Mid-Cap Stock Gainers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?
Lekha Gupta - Mar 16, 2025, 10:40AM

Tuesday, March 11, 2025

Truist Securities Maintains Buy on Protagonis...
Benzinga Newsdesk - Mar 11, 2025, 12:38PM
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor - Mar 11, 2025, 9:12AM
BMO Capital Maintains Outperform on Protagoni...
Benzinga Newsdesk - Mar 11, 2025, 8:50AM
HC Wainwright & Co. Maintains Buy on Protagon...
Benzinga Newsdesk - Mar 11, 2025, 6:25AM

Monday, March 10, 2025

Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
Avi Kapoor - Mar 10, 2025, 12:15PM
Why Is Protagonist Therapeutics Stock Trading Higher On Monday?
Vandana Singh - Mar 10, 2025, 10:04AM
Citizens Capital Markets Reiterates Market Ou...
Benzinga Newsdesk - Mar 10, 2025, 9:35AM
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk - Mar 10, 2025, 8:21AM
Protagonist Says All Three Doses Met The Prim...
Benzinga Newsdesk - Mar 10, 2025, 8:19AM
Protagonist Reports Top Line Results From Pha...
Benzinga Newsdesk - Mar 10, 2025, 8:19AM
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Mar 10, 2025, 7:17AM
Reported Saturday, Protagonist Reports Icotro...
Benzinga Newsdesk - Mar 10, 2025, 3:18AM

Tuesday, March 04, 2025

JP Morgan Maintains Overweight on Protagonist...
Benzinga Newsdesk - Mar 4, 2025, 7:02AM

Monday, March 03, 2025

HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Mar 3, 2025, 12:41PM
Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer
Vandana Singh - Mar 3, 2025, 12:01PM
Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk - Mar 3, 2025, 9:28AM
Protagonist and Takeda's Rusfertide Meets All...
Benzinga Newsdesk - Mar 3, 2025, 6:46AM

Monday, February 24, 2025

Goldman Sachs Maintains Neutral on Protagonis...
Benzinga Newsdesk - Feb 24, 2025, 11:18AM
HC Wainwright & Co. Maintains Buy on Protagon...
Benzinga Newsdesk - Feb 24, 2025, 6:16AM

Friday, February 21, 2025

Protagonist Therapeutics Reports Q4 EPS Of $1...
Benzinga Newsdesk - Feb 21, 2025, 7:09AM

Friday, February 07, 2025

JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk - Feb 7, 2025, 12:14PM
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Feb 7, 2025, 8:04AM

Tuesday, February 04, 2025

JP Morgan Maintains Overweight on Protagonist...
Benzinga Newsdesk - Feb 4, 2025, 10:07AM

Tuesday, December 10, 2024

HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Dec 10, 2024, 7:54AM

Friday, December 06, 2024

BMO Capital Initiates Coverage On Protagonist...
Benzinga Newsdesk - Dec 6, 2024, 6:15AM

Friday, November 22, 2024

Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk - Nov 22, 2024, 11:08AM
Natural Grocers By Vitamin Cottage, Elastic, Matthews International, Gap And Other Big Stocks Moving Higher On Friday
Avi Kapoor - Nov 22, 2024, 10:59AM
HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Nov 22, 2024, 6:55AM

Thursday, November 21, 2024

Protagonist Selects PN-881 As Development Can...
Benzinga Newsdesk - Nov 21, 2024, 4:12PM

Tuesday, November 19, 2024

HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Nov 19, 2024, 6:37AM

Wednesday, November 13, 2024

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights - Nov 13, 2024, 12:35PM

Monday, November 11, 2024

HC Wainwright & Co. Reiterates Buy on Protago...
Benzinga Newsdesk - Nov 11, 2024, 10:05AM

Thursday, November 07, 2024

Protagonist Therapeutics Q3 EPS $(0.54) Beats...
Benzinga Newsdesk - Nov 7, 2024, 5:07PM

Tuesday, November 05, 2024

Wedbush Initiates Coverage On Protagonist The...
Benzinga Newsdesk - Nov 5, 2024, 4:32AM

Tuesday, September 24, 2024

TD Cowen Initiates Coverage On Protagonist Th...
Benzinga Newsdesk - Sep 24, 2024, 5:55AM

Thursday, September 12, 2024

HC Wainwright & Co. Maintains Buy on Protagon...
Benzinga Newsdesk - Sep 12, 2024, 11:38AM

Tuesday, September 10, 2024

Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Vandana Singh - Sep 10, 2024, 1:17PM

Monday, September 09, 2024

Protagonist Therapeutics shares are trading h...
Benzinga Newsdesk - Sep 9, 2024, 1:26PM
Truist Securities Initiates Coverage On Prota...
Benzinga Newsdesk - Sep 9, 2024, 9:47AM

Wednesday, August 07, 2024

JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk - Aug 7, 2024, 4:37PM
HC Wainwright & Co. Maintains Buy on Protagon...
Benzinga Newsdesk - Aug 7, 2024, 4:26PM

Tuesday, August 06, 2024

Protagonist Says Cash And Equivalents Of $595...
Benzinga Newsdesk - Aug 6, 2024, 7:53AM
Protagonist Therapeutics Q2 2024 GAAP EPS $(0...
Benzinga Newsdesk - Aug 6, 2024, 7:52AM
Protagonist Therapeutics shares are trading l...
Benzinga Newsdesk - Aug 6, 2024, 7:50AM

Sunday, July 28, 2024

ViaSat & AST SpaceMobile Are Among Top 6 Mid Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Lekha Gupta - Jul 28, 2024, 2:17PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved